BiotechTube
NeuraNova

NeuraNova

Boston, United States· Est.
neuranova.co
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

NeuraNova is an early-stage diagnostics company developing portable, low-cost medical devices for rapid stroke detection. Its core technology platform includes patented systems like S.T.E.D.I. and the F.L.A.S.H. Device, designed to enable fast assessment of stroke and hemorrhage at the point of need. The company aims to address a critical unmet need in neurovascular care by accelerating diagnosis, thereby improving patient outcomes in a large and growing market. As a private, pre-revenue entity, NeuraNova is building its leadership team and commercial strategy following a rebrand from StrokeDx.

StrokeNeurovascular

Technology Platform

Portable sensor platform utilizing patented technologies (S.T.E.D.I. and F.L.A.S.H. Device) for rapid, transcranial detection and assessment of stroke and hemorrhage, designed to be low-cost and usable outside traditional imaging suites.

Opportunities

The large and growing global stroke market, combined with the critical need for faster diagnosis, presents a significant opportunity.
The low-cost, portable nature of the technology allows for deployment in pre-hospital and resource-limited settings, vastly expanding accessibility and enabling earlier treatment.

Risk Factors

Key risks include the technical and clinical validation of a novel diagnostic platform, navigating complex regulatory pathways for medical devices, and achieving commercial adoption against established standard-of-care imaging.
As a pre-revenue startup, securing sufficient funding to reach these milestones is also a persistent risk.

Competitive Landscape

The competitive landscape includes other companies developing portable stroke assessment tools, such as those using EEG, advanced ultrasound, or other biosensing technologies. NeuraNova must differentiate its technology on accuracy, speed, ease of use, and cost to compete against these alternatives and the entrenched standard of CT/MRI scanners.

More companies in Diagnostics & Precision Medicine →More companies in United States →